Perrigo explores sale of royalties of drug Tysabri -sources

Sept 16 (Reuters) - Perrigo Company Plc, the generic drug manufacturer targeted by activist investor Starboard Value LP, is exploring a sale of the royalties it receives from sales of multiple sclerosis drug Tysabri, people familiar with the matter said.